Grounded in clinical need
Our starting point is the person whose poor liver reserve limits the treatment options available to them.
Science with purpose.People with conviction.
Clinical insight, molecular science, and the determination to make more possible for people living with liver disease.
Meet our team
OUR STORY
Clinical insight.
Translational ambition.
Apterna was founded by Professor Nagy Habib, Dr Declan Doogan, and Joanna Nichols to connect clinical need with the possibilities of RNA therapeutics. Healthcare innovation is led by Dr Arash Dehkordi.
Our preclinical, liver-first programme is designed to restore function in patients whose disease limits access to curative care. We begin with a defined need and build the evidence for what comes next.
HOW WE WORK
Ambition, with discipline.
Built for translation
Molecular science, clinical development, and practical execution come together from the earliest stages.
Progress through partnership
We aim to advance key proof-of-concept work internally, then collaborate for broader development and reach.
OUR PEOPLE
Different disciplines.
One shared conviction.
COLLABORATION
Science grows through connection.
Academic collaboration
Research relationships with Imperial College London and City of Hope connect Apterna with expertise in RNA biology and translational science.
Translational partnerships
Specialist development and manufacturing partners support a route from laboratory research towards clinical readiness.
A wider scientific community
We welcome collaborations across academia, biotechnology, clinical networks, and pharmaceutical development.
CONTINUE EXPLORING
